Загрузка...
Oral 5‐aminosalicylic acid for induction of remission in ulcerative colitis
BACKGROUND: Oral 5‐aminosalicylic acid (5‐ASA) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. Previously, it was found that 5‐ASA drugs in doses of at least 2 g/day, were more effective than placebo but no more effective th...
Сохранить в:
| Опубликовано в: : | Cochrane Database Syst Rev |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley & Sons, Ltd
2016
|
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7045743/ https://ncbi.nlm.nih.gov/pubmed/27101467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000543.pub4 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|